Analytical Data
-
Gene name
PRSS35
- Application
-
Alternative Names
PRSS35; C6orf158; UNQ522/PRO1057; Inactive serine protease 35
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N3Z0
-
Expression Region
17-413 aa
-
AA Sequence
LIDG SEMEWDFMWH LRKVPRIVSE RTFHLTSPAF EADAKMMVNT VCGIECQKEL PTPSLSELED YLSYETVFEN GTRTLTRVKV QDLVLEPTQN ITTKGVSVRR KRQVYGTDSR FSILDKRFLT NFPFSTAVKL STGCSGILIS PQHVLTAAHC VHDGKDYVKG SKKLRVGLLK MRNKSGGKKR RGSKRSRREA SGGDQREGTR EHLRERAKGG RRRKKSGRGQ RIAEGRPSFQ WTRVKNTHIP KGWARGGMGD ATLDYDYALL ELKRAHKKKY MELGISPTIK KMPGGMIHFS GFDNDRADQL VYRFCSVSDE SNDLLYQYCD AESGSTGSGV YLRLKDPDKK NWKRKIIAVY SGHQWVDVHG VQKDYNVAVR ITPLKYAQIC LWIHGNDANC AYG
-
Molecular Weight
47.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PRSS35, a member of the serine protease family, has garnered attention due to its unique expression pattern and potential roles in various physiological processes. This protease is primarily expressed in the testis and has been implicated in male fertility and reproductive health. Its involvement in sperm maturation and movement suggests a critical function in the male reproductive system. Recent studies indicate that PRSS35 may play a role in the degradation of extracellular matrix proteins, which is vital for spermatozoa motility and overall reproductive success. Additionally, investigations into PRSS35 have revealed correlations with certain pathological conditions, including infertility and cancer, thus highlighting its potential as a biomarker or therapeutic target. The recombinant protein form of PRSS35 allows for in-depth biochemical analyses, facilitating the understanding of its enzymatic mechanisms, substrate specificity, and interactions with other molecules. Research on PRSS35 not only aims to elucidate its biological significance but also explores its potential applications in reproductive medicine and oncology, marking it as a promising candidate for future studies focused on reproductive health and disease intervention.
